Target intelligence / Profile preview

Protein kinase AMP-activated catalytic subunit alpha 2 (AMPKα2)

Target
AMPKα2
Molecular classification
Enzyme (Serine/threonine protein kinase), Energy sensor protein kinase, Member of the AMPK subfamily
01

Overview

Protein kinase AMP‑activated catalytic subunit alpha 2 (AMPKα₂) is one of two catalytic isoforms forming part of the heterotrimeric AMP‑activated protein kinase complex. This enzyme acts as a central regulator (“energy sensor”) maintaining cellular energy homeostasis by responding to changes in intracellular ATP/AMP ratios. Upon activation—typically triggered by increased cellular stress or low nutrient states—AMPKα₂ phosphorylates multiple downstream targets involved in catabolic processes that generate ATP while inhibiting anabolic processes consuming ATP. The PRKAA₂ gene encodes this isoform; it is expressed broadly but shows tissue-specific functions distinct from its close homolog AMPKα₁. Dysregulation has been implicated in metabolic diseases such as diabetes and obesity, cardiovascular pathologies, certain cancers where it can promote tumor immune escape via T-cell exhaustion mechanisms, neurodegeneration linked to impaired bioenergetics, and other conditions involving altered cell metabolism.

Other names
AMPK alpha-2 chainAMP-activated protein kinase alpha 2 subunitPRKAA2ACACA kinaseAcetyl-CoA carboxylase kinaseHMGCR kinaseHydroxymethylglutaryl-CoA reductase kinase
02

Mechanism of action

Drugs targeting this molecule typically act by one or more of the following mechanisms: – Allosteric activation by mimicking AMP binding to regulatory γ subunits – Indirect activation through upstream kinases that phosphorylate Thr174 on the α‑2 catalytic domain – Inhibition or modulation of downstream targets regulated by AMPK phosphorylation

03

Biological functions

Regulation of cellular energy metabolism (energy homeostasis)Phosphorylation of metabolic enzymes and transcription regulators involved in energy metabolism (e.g., CRTC2/TORC2, FOXO3)Stimulation of glucose uptake in skeletal muscleRegulation of mitochondrial biogenesis, autophagy, glycolysis/gluconeogenesis, β‑oxidation/lipogenesis, and protein metabolism
04

Disease associations

Cancer (including tumor immune escape mechanisms)Cardiovascular diseaseMetabolic disorders such as type 2 diabetes and obesityNeurodegenerative disease (implicated via energy regulation roles)Inflammation-related conditions
05

Safety considerations

Notable safety concerns with systemic modulation include potential effects on cardiac function, hypoglycemia risk due to increased glucose uptake/utilization, possible interference with cell proliferation/apoptosis balance relevant to cancer therapy. Isoform-specific targeting remains challenging due to high homology between α1 and α2 isoforms.
06

Interacting drugs

Metformin (indirect activator via upstream pathways)

2 more in the full profile.

07

Biomarkers

Potential biomarkers include phosphorylated acetyl-CoA carboxylase levels in tissues/cells as a readout for AMPK activity. Expression levels or phosphorylation status of PRKAA2 itself may also serve as pharmacodynamic markers in research settings.

Beyond the preview

Go deeper on Protein kinase AMP-activated catalytic subunit alpha 2 (AMPKα2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase AMP-activated catalytic subunit alpha 2 (AMPKα2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call